XBiotech Inc (NASDAQ: XBIT) stock closed at $5.00 on 1/12/24 after a major increase of 13.1%. Moreover, trading volume in this advance was unusually high at 187% of normal. The stock has risen 17.9% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, XBIT is expected to continue to be Value Creation neutral.
XBiotech has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. XBiotech has a slightly negative Power Rating of 32 and a slightly negative Appreciation Score of 30, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment